Ro, the $7 billion healthcare startup, has a high-stakes strategy to take off-brand Ozempic mainstre
Almost as long as the weight-loss shot Wegovy's been on the market, dozens of websites, telehealth clinics, and med-spas have been hawking cheaper knock-off versions. Now, these custom-made "compounded" shots are starting to go mainstream.